8-K: FIGS Inc. Reports Mixed Q4 and Full Year 2023 Results; CFO Resigns

FIGS Inc. announced its Q4 and full year 2023 financial results, highlighted by a CFO resignation and a mixed financial performance.

Summary

• FIGS Inc. released its fourth quarter and full year 2023 financial results, showing a mixed performance.
• Full year net revenues increased by 7.9% year-over-year to $545.6 million, while fourth quarter net revenues were flat at $144.9 million.
• The company experienced a $4.7 million accounting reclassification between net revenues and selling expenses related to duty subsidies in Canada.
• Full year net income was $22.6 million, with a net income margin of 4.1%, while adjusted EBITDA margin was 15.8%.
• The company reduced inventory levels by 33% and generated $100 million in cash flow from operations for the full year.
• Active customers increased by 13% year-over-year to 2.6 million, but net revenue per active customer decreased by 5% to $210.
• The average order value (AOV) increased by 2.7% year-over-year to $115.
• The company's CFO, Daniella Turenshine, resigned effective April 12, 2024, and Kevin Fosty was appointed as Interim CFO.
• FIGS anticipates a challenging 2024 with net revenue growth expected to be down mid-single digits to flat and adjusted EBITDA margin between 11% and 12%.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company achieved growth in 2023 and reduced inventory, the resignation of the CFO, the flat Q4 revenue, and the lowered guidance for 2024 temper the positive aspects.

Positives

• Full year net revenues increased by 7.9% year-over-year.
• The company achieved a net income of $22.6 million for the full year.
• FIGS successfully reduced inventory levels by 33% in 2023.
• The company generated $100 million in cash flow from operations for the full year.
• Active customers increased by 13% year-over-year.
• Average order value increased by 2.7% year-over-year.
• Operating expenses decreased by 12.5% year over year in Q4.

Negatives

• Fourth quarter net revenues were flat year-over-year.
• Gross margin decreased by 70 basis points year-over-year in Q4.
• Net revenue per active customer decreased by 5% year-over-year.
• Full year gross margin decreased by 100 basis points year-over-year.
• Adjusted EBITDA margin decreased from 17.2% to 15.8% year-over-year for the full year.
• The company expects net revenue growth to be down mid-single digits to flat in 2024.
• Adjusted EBITDA margin is projected to be between 11% and 12% for 2024.

Risks

• The company anticipates that macroeconomic factors will impact demand in 2024.
• The healthcare workforce related stress is expected to affect the company's community.
• The company faces challenges in reigniting demand and rebuilding momentum.
• There is a risk associated with the transition of the CFO role.
• The company's future performance is subject to various risks and uncertainties, including maintaining historical growth and profitability.

Future Outlook

FIGS expects net revenue growth to be down mid-single digits to flat in 2024, with an adjusted EBITDA margin between 11% and 12%. The company acknowledges macroeconomic headwinds and healthcare workforce stress impacting demand.

Management Comments

• Trina Spear, Chief Executive Officer and Co-Founder, stated that they delivered strong growth and profitability in 2023, reduced inventory levels, and generated cash flow from operations.
• Trina Spear also mentioned that they are taking swift action to rebuild momentum and reignite the word of mouth flywheel.
• Daniella Turenshine, Chief Financial Officer, commented that she played an integral role in building FIGS into a more than half a billion dollar business.
• Daniella Turenshine also expressed confidence in Kevin Fosty and the finance organization to execute during the transition period.

Industry Context

The announcement reflects the challenges faced by direct-to-consumer brands in a fluctuating macroeconomic environment. The company's focus on healthcare apparel positions it in a niche market, but it is still subject to broader economic trends and workforce dynamics.

Comparison to Industry Standards

• FIGS' revenue growth of 7.9% for the full year is moderate compared to some high-growth e-commerce companies, but it is a positive result in the current economic climate.
• The decrease in gross margin suggests potential pricing pressures or increased costs, which is a common challenge in the apparel industry.
• The adjusted EBITDA margin of 15.8% is a reasonable level of profitability, but the projected decrease to 11-12% in 2024 indicates potential headwinds.
• Compared to companies like Lululemon, which has a higher gross margin, FIGS has room for improvement in operational efficiency and pricing strategies.
• Stitch Fix, mentioned in the document as a previous employer of the interim CFO, has faced similar challenges in customer retention and revenue growth, highlighting the competitive nature of the direct-to-consumer market.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the lowered guidance for 2024 and the CFO transition.
• Employees may experience uncertainty due to the CFO change.
• Customers may be affected by any changes in product offerings or marketing strategies.
• Suppliers may need to adjust to any changes in the company's inventory management.

Next Steps

• The company will conduct a search for a permanent Chief Financial Officer.
• The company will focus on reigniting demand and rebuilding momentum.
• The company will implement strategic initiatives to unlock long-term potential.

Key Dates

Keywords

FIGS, financial results, net revenue, EBITDA, CFO, healthcare apparel, direct-to-consumer, inventory, active customers, gross margin